GLP-1 Based Therapeutics: Simultaneously Combating T2DM and Obesity
Frontiers in Neuroscience - Switzerland
doi 10.3389/fnins.2015.00092
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 20, 2015
Authors
Publisher
Frontiers Media SA